Listes récapitulatives

Seneste opdatering :
28/04/2024

Bversigter

Denne side tillader kryds-konsultation af stabilitetsinformation.
Stabilitet af farmaceutiske tilberedninger	Faktorer der påvirker stabiliteten	Kompatibilitet

A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y -

Bevacizumab

25 mg/ml

2-8°C

4525

Bevacizumab

25 mg/ml

2-8°C

4744

Bevacizumab

25 mg/ml

2-8°C

4745

Bevacizumab

25 mg/ml

4°C

4714

Cabazitaxel

20 mg/ml

25°C

4761

Cetuximab

5 mg/ml

25°C

4755

Durvalumab

50 mg/ml

2-8°C

4767

Durvalumab

50 mg/ml

20-25°C

4767

Durvalumab

50 mg/ml

20-25°C

4772

Durvalumab

50 mg/ml

4°C

4772

Ipilimumab

5 mg/ml

25°C

3850

Ipilimumab

5 mg/ml

4°C

3850

Nivolumab

10 mg/ml

2-8°C

4505

Pemetrexed diarginine

25 mg/ml

2-8°C

4702

Pemetrexed diarginine

25 mg/ml

25°C

4702

Rituximab

10 mg/ml

2-4°C

4016

Rituximab

10 mg/ml

25°C

4016

Trastuzumab

21 mg/ml

2-5°C

4191

Mentions Légales